In case you missed them, here are our top stories from May 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings...
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
71 readers recommended
Oculis' OCS-01 eye drops show promising results in phase 3 trials for diabetic macular edema treatment. Uncover a potential revolution in non-invasive eye care solutions.
79 readers recommended
Early findings from a phase 3 clinical trial demonstrated that participants treated with 50 mg oral semaglutide achieved a remarkable weight loss of 17.4%. This research...
58 readers recommended
Farxiga (dapagliflozin), a SGLT-2 inhibitor, has officially been approved by the FDA to treat all types of heart failure, a common diabetes complication.
50 readers recommended
The FDA has cleared the Omnipod GO: a discreet, water-resistant insulin pod with up to 3 days of wear. Enjoy the freedom and convenience to manage your diabetes.
66 readers recommended
The FDA recently cleared a new experimental drug for type 1 diabetes to begin a phase 2 clinical trial. If approved, the drug would be the first therapy to specifically...
124 readers recommended
Researchers released clinical trial data on a new treatment for type 2 diabetes that may help the body’s insulin-producing cells regenerate. 78% of the clinical trial’s...
91 readers recommended
Mark Cuban’s Cost Plus Drug Company recently added SGLT-2 inhibitor Invokana to its list of available medications. The company, which uses an innovative business model...
45 readers recommended
California Gov. Gavin Newsom announced a $50-million contract with Civica Rx to produce the state’s own insulin, adding to the recent new policies aiming to make this...
41 readers recommended
Tandem Diabetes announced clinical trial results that showed from the very first day, children with type 1 diabetes who used the Control-IQ hybrid closed loop technology...
67 readers recommended
A clinical trial is recruiting participants with type 2 diabetes and chronic kidney disease (CKD) to see how well a combination of glucose-lowering and kidney-protective...
59 readers recommended
Following Eli Lilly’s recent announcement of a $35 monthly limit on out-of pocket costs, Sanofi announced a $35 cost cap on Lantus, and Novo Nordisk pledged to reduce...
131 readers recommended
Eli Lilly announced today that it will cut the list prices for its most commonly prescribed insulins, including Humalog and Humulin, by 70%. The drug maker will also...
268 readers recommended
At ATTD 2023, a panel of experts discussed the latest medications for weight loss and the treatment of obesity. The panel highlighted two FDA approved drugs, as well as...
54 readers recommended
The low-cost drug verapamil, a widely available generic drug for blood pressure, was shown to preserve insulin-producing beta cell function in young people, aged 7-17,...
97 readers recommended
Researchers at this week’s 2023 Advanced Technologies and Treatments for Diabetes (ATTD) conference in Berlin provided an update on icodec and efsitora, two new basal...
51 readers recommended
During his State of the Union Address on Feb. 7, President Joe Biden called on congress to expand the cap on monthly insulin prices to all people with diabetes.
193 readers recommended
The world’s hottest new miracle drug for type 2 diabetes, Ozempic (semaglutide), has surged in popularity among people with and without diabetes looking to lose weight,...
40 readers recommended
The FDA approved a new medication for type 2 diabetes called Brenzavvy (bexagliflozin). Clinical trials showed that people who used the drug saw an average A1C...
127 readers recommended
The FDA has just announced that Rybelsus has now been approved as an initial treatment option for type 2 diabetes. In addition to the glucose-lowering effects, Rybelsus...